---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-059806"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2023-07-26T23:59:59+00:00"
generated_at: "2026-06-13T02:24:52.716927+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Unicycive regains Nasdaq minimum market value compliance

## Summary
- Received non-compliance notice on May 17, 2023 for MVLS below $35M.
- MVLS remained above $35M for 10 consecutive business days ending July 24.
- Nasdaq confirmed compliance on July 25, 2023.
- Delisting risk removed; stock continues trading on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-23-059806
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2023-07-26T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390023059806/0001213900-23-059806-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390023059806/ea182337-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-059806
- JSON: https://secwatch.observer/filing/0001213900-23-059806.json
- Plain text: https://secwatch.observer/filing/0001213900-23-059806.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.